WallStSmart

Innospec Inc (IOSP)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 1225% more annual revenue ($24.41B vs $1.84B). SHW leads profitability with a 11.0% profit margin vs 6.6%. IOSP appears more attractively valued with a PEG of 0.66. IOSP earns a higher WallStSmart Score of 68/100 (B-).

IOSP

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 5.5Value: 6.3Quality: 8.5
Piotroski: 4/9Altman Z: 4.08

SHW

Buy

60

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for IOSP.

SHWUndervalued (+2.3%)

Margin of Safety

+2.3%

Fair Value

$330.90

Current Price

$323.31

$7.59 discount

UndervaluedFair: $330.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IOSP5 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.0810/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.668/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

EPS GrowthGrowth
33.0%8/10

Earnings expanding 33.0% YoY

SHW3 strengths · Avg: 9.0/10
Return on EquityProfitability
69.7%10/10

Every $100 of equity generates 70 in profit

Market CapQuality
$78.49B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

IOSP2 concerns · Avg: 2.5/10
Profit MarginProfitability
6.6%3/10

6.6% margin — thin

Free Cash FlowQuality
$-15.60M2/10

Negative free cash flow — burning cash

SHW4 concerns · Avg: 3.5/10
PEG RatioValuation
2.054/10

Expensive relative to growth rate

P/E RatioValuation
29.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Price/BookValuation
20.2x2/10

Trading at 20.2x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : IOSP

The strongest argument for IOSP centers on Debt/Equity, Altman Z-Score, PEG Ratio. Revenue growth of 11.8% demonstrates continued momentum. PEG of 0.66 suggests the stock is reasonably priced for its growth.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.

Bear Case : IOSP

The primary concerns for IOSP are Profit Margin, Free Cash Flow.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Altman Z-Score. Debt-to-equity of 3.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

SHW carries more volatility with a beta of 1.09 — expect wider price swings.

IOSP is growing revenue faster at 11.8% — sustainability is the question.

SHW generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor SPECIALTY CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

IOSP scores higher overall (68/100 vs 60/100) and 11.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Innospec Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, the rest of North America, the United Kingdom, the rest of Europe, and internationally. The company is headquartered in Englewood, Colorado.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?